Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
Mã chứng khoánEMBC
Tên công tyEmbecta Corp
Ngày IPOMar 21, 2022
Giám đốc điều hànhKurdikar (Devdatt)
Số lượng nhân viên1850
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhMar 21
Địa chỉ300 Kimball Drive
Thành phốPARSIPPANY
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện07054
Điện thoại18624010000
Trang webhttps://www.embecta.com/
Mã chứng khoánEMBC
Ngày IPOMar 21, 2022
Giám đốc điều hànhKurdikar (Devdatt)